216 related articles for article (PubMed ID: 31004063)
1. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.
Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.
Wang ZH; Xiang J; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Wu S; Wang JZ; Ye K
Cell Rep; 2019 Jul; 28(3):655-669.e5. PubMed ID: 31315045
[TBL] [Abstract][Full Text] [Related]
3. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
4. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease.
Liao J; Chen C; Ahn EH; Liu X; Li H; Edgington-Mitchell LE; Lu Z; Ming S; Ye K
Neuropharmacology; 2021 Oct; 197():108737. PubMed ID: 34343610
[TBL] [Abstract][Full Text] [Related]
5. BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.
Wang ZH; Wu W; Kang SS; Liu X; Wu Z; Peng J; Yu SP; Manfredsson FP; Sandoval IM; Liu X; Wang JZ; Ye K
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135302
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis.
Wu Z; Chen C; Kang SS; Liu X; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140411
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
8. TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies.
Xia Y; Wang ZH; Liu P; Edgington-Mitchell L; Liu X; Wang XC; Ye K
Mol Psychiatry; 2021 Jul; 26(7):2943-2963. PubMed ID: 32782380
[TBL] [Abstract][Full Text] [Related]
9. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
10. Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.
Liu XH; Geng Z; Yan J; Li T; Chen Q; Zhang QY; Chen ZY
Neurobiol Dis; 2015 Feb; 74():377-91. PubMed ID: 25484286
[TBL] [Abstract][Full Text] [Related]
11. Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.
Chen C; Zhou Y; Wang H; Alam A; Kang SS; Ahn EH; Liu X; Jia J; Ye K
EMBO J; 2021 Sep; 40(17):e106320. PubMed ID: 34260075
[TBL] [Abstract][Full Text] [Related]
12. Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.
Wang ZH; Liu P; Liu X; Manfredsson FP; Sandoval IM; Yu SP; Wang JZ; Ye K
Mol Cell; 2017 Sep; 67(5):812-825.e5. PubMed ID: 28826672
[TBL] [Abstract][Full Text] [Related]
13. Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.
Kang SS; Ahn EH; Ye K
Exp Mol Med; 2020 Aug; 52(8):1275-1287. PubMed ID: 32859953
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.
Michalski B; Corrada MM; Kawas CH; Fahnestock M
Neurobiol Aging; 2015 Dec; 36(12):3130-3139. PubMed ID: 26410307
[TBL] [Abstract][Full Text] [Related]
15. Optimized TrkB Agonist Ameliorates Alzheimer's Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase.
Chen C; Ahn EH; Liu X; Wang ZH; Luo S; Liao J; Ye K
ACS Chem Neurosci; 2021 Jul; 12(13):2448-2461. PubMed ID: 34106682
[TBL] [Abstract][Full Text] [Related]
16. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
17. Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease.
Bharani KL; Ledreux A; Gilmore A; Carroll SL; Granholm AC
Neurobiol Aging; 2020 Mar; 87():49-59. PubMed ID: 31882186
[TBL] [Abstract][Full Text] [Related]
18. Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.
Wang ZH; Liu P; Liu X; Yu SP; Wang JZ; Ye K
J Exp Med; 2018 Dec; 215(12):3038-3056. PubMed ID: 30373880
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
[TBL] [Abstract][Full Text] [Related]
20. Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ
Sajan MP; Hansen BC; Higgs MG; Kahn CR; Braun U; Leitges M; Park CR; Diamond DM; Farese RV
Neurobiol Aging; 2018 Jan; 61():225-237. PubMed ID: 29032894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
